Key Highlights
- Dr. Robert Ruffolo, with his extensive experience in pharmaceuticals, joins the external advisory board of the Rice Biotech Launch Pad.
- Ruffolo’s expertise expected to significantly boost the accelerator’s efforts in translating medical technologies into therapeutic breakthroughs.
- The Launch Pad, a key player in Houston’s medical innovation ecosystem, aims to advance from concept to commercialization.
Source: PR Newswire
Notable Quotes
- “Kicking off 2024 with the significant announcement of the addition of Dr. Ruffolo to the external advisory board is setting us up to have another successful year,” – Paul Wotton, Executive Director and Chairman at Rice Biotech Launch Pad
- “Dr. Ruffolo brings immense value to the Rice Biotech Launch Pad as an adviser to drive drug development,” – Omid Veiseh, Associate Professor of Bioengineering at Rice University
- “The Rice Biotech Launch Pad is one of the most forward-looking and technologically innovative teams in the drug development space right now,” – Dr. Robert Ruffolo, Advisory Board at Rice Biotech
SoH's Take
The inclusion of Dr. Robert Ruffolo on the Rice Biotech Launch Pad’s external advisory board marks a pivotal moment in the trajectory of this innovative accelerator. With Dr. Ruffolo’s distinguished career and his track record of launching 37 new drugs, the Launch Pad is positioned to significantly enhance its capability in converting medical research into tangible patient treatments. His experience and network within the pharmaceutical industry are invaluable assets that could catalyze the development of new therapies, fostering a robust ecosystem of medical innovation in Houston. The Launch Pad’s collaboration with the Texas Medical Center further underscores its potential impact, promising exciting advancements in drug discovery and development.
